Stable correction of a genetic deficiency in human cells by an episome carrying a 115 kb genomic transgene.
Persistent expression of a transgene at therapeutic levels is required for successful gene therapy, but many small vectors with heterologous promoters are prone to vector loss and transcriptional silencing. The delivery of genomic DNA would enable genes to be transferred as complete loci, including...
Main Authors: | Wade-Martins, R, White, R, Kimura, H, Cook, P, James, MR |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2000
|
Similar Items
-
Episomal transgene expression in pluripotent stem cells.
by: Lufino, M, et al.
Published: (2011) -
Advances in high-capacity extrachromosomal vector technology: episomal maintenance, vector delivery, and transgene expression.
by: Lufino, M, et al.
Published: (2008) -
Sequences adjacent to oriP improve the persistence of Epstein-Barr virus-based episomes in B cells.
by: White, R, et al.
Published: (2001) -
Long-term stability of large insert genomic DNA episomal shuttle vectors in human cells.
by: Wade-Martins, R, et al.
Published: (1999) -
An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency.
by: Lufino, M, et al.
Published: (2007)